Legal & General Group

Legal & General Group Portfolio holdings

AUM $403B
 

Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.

This Quarter Return
+14.45%
1 Year Return
+24.44%
3 Year Return
+100.62%
5 Year Return
+177.57%
10 Year Return
+421.39%
AUM
$403B
AUM Growth
+$403B
Cap. Flow
-$2.49B
Cap. Flow %
-0.62%
Top 10 Hldgs %
32.43%
Holding
3,602
New
227
Increased
1,896
Reduced
1,081
Closed
186

Sector Composition

1 Technology 34.3%
2 Financials 13.54%
3 Consumer Discretionary 9.84%
4 Healthcare 9.2%
5 Communication Services 8.89%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ACRV icon
3476
Acrivon Therapeutics
ACRV
$42.2M
-839 Closed -$1.7K
ADVM icon
3477
Adverum Biotechnologies
ADVM
$64.6M
-1,797 Closed -$7.85K
AGEN
3478
Agenus
AGEN
$133M
-1,927 Closed -$2.9K
AKYA
3479
DELISTED
Akoya BioSciences
AKYA
-2,510 Closed -$3.49K
ALXO icon
3480
ALX Oncology
ALXO
$62.7M
-3,860 Closed -$2.4K
AMPY icon
3481
Amplify Energy
AMPY
$165M
-3,621 Closed -$13.5K
AMTX icon
3482
Aemetis
AMTX
$161M
-3,112 Closed -$5.42K
APLT icon
3483
Applied Therapeutics
APLT
$71M
-56,114 Closed -$27.4K
ATNM icon
3484
Actinium Pharmaceuticals
ATNM
$55.5M
-3,713 Closed -$5.96K
ATOS icon
3485
Atossa Therapeutics
ATOS
$98.5M
-11,829 Closed -$7.96K
AUTL
3486
Autolus Therapeutics
AUTL
$399M
-299,836 Closed -$463K
BAER icon
3487
Bridger Aerospace
BAER
$113M
-1,125 Closed -$1.28K
BDTX icon
3488
Black Diamond Therapeutics
BDTX
$157M
-3,825 Closed -$5.93K
BLNK icon
3489
Blink Charging
BLNK
$124M
-9,362 Closed -$8.59K
BLUE
3490
DELISTED
bluebird bio
BLUE
-939 Closed -$4.58K
BMEA icon
3491
Biomea Fusion
BMEA
$116M
-3,392 Closed -$7.24K
CABA icon
3492
Cabaletta Bio
CABA
$133M
-3,961 Closed -$5.49K
CAMP icon
3493
CAMP4 Therapeutics Corporation Common Stock
CAMP
$30.6M
-708 Closed -$2.81K
CBUS icon
3494
Cibus
CBUS
$70.4M
-1,293 Closed -$2.42K
CCCC icon
3495
C4 Therapeutics
CCCC
$185M
-5,063 Closed -$8.08K
CDLX icon
3496
Cardlytics
CDLX
$54.3M
-4,644 Closed -$8.45K
CHGG icon
3497
Chegg
CHGG
$159M
-9,185 Closed -$5.87K
CHPT icon
3498
ChargePoint
CHPT
$263M
-309,866 Closed -$187K
CRBP icon
3499
Corbus Pharmaceuticals
CRBP
$115M
-1,103 Closed -$5.86K
CRBU icon
3500
Caribou Biosciences
CRBU
$174M
-6,941 Closed -$6.34K